Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01041521Phase 4Completed
Phase 4, randomised, double-blind trial in hypertriglyceridemia comparing Lovaza with Placebo (2 arms). Primary endpoint: Triglyceride Level at 24 months. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01041521.